1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Gaspari, Z.
Patthy, A.
Graf, L.
Perczel, A.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
IX
Eur.J.Biochem.
EJBCAI
0262
0014-2956
269
527
537
10.1046/j.0014-2956.2001.02685.x
11856311
Comparative structure analysis of proteinase inhibitors from the desert locust, Schistocerca gregaria.
2002
10.2210/pdb1kgm/pdb
pdb_00001kgm
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
1
SINGLE WAVELENGTH
M
1
1.0
3659.175
SERINE PROTEASE INHIBITOR I
Residues 57-91
1
syn
polymer
Schistocerca gregaria chymotrypsin inhibitor (SGCI)
no
no
EVTCEPGTTFKDKCNTCRCGSDGKSAACTLKACPQ
EVTCEPGTTFKDKCNTCRCGSDGKSAACTLKACPQ
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
database_2
pdbx_struct_assembly
pdbx_struct_oper_list
repository
Initial release
Version format compliance
Version format compliance
Database references
Derived calculations
1
0
2001-12-12
1
1
2008-04-27
1
2
2011-07-13
1
3
2022-02-23
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
PROTEINASE INHIBITOR PMP-C (NMR, 36 STRUCTURES)
SOLUTION STRUCTURE OF THE SMALL SERINE PROTEASE INHIBITOR SGCI[L30R, K31M]
SOLUTION STRUCTURE OF THE SMALL SERINE PROTEASE INHIBITOR SGTI
RCSB
Y
RCSB
2001-11-28
REL
REL
Solid-phase synthesis, Fmoc strategy, Sequence naturally found in Schistocerca gregaria (desert locust)
sample
structures with acceptable covalent geometry,structures with the least restraint violations
100
10
2D NOESY
0
3.0
ambient
300
K
Structures are based on 526 distance restraints (128 long-range)
simulated annealing
5
closest to the average
2.5mM SGCI NA; 90% H2O, 10% D2O
90% H2O/10% D2O
Brunger
refinement
X-PLOR
3.851
Brunger
structure solution
X-PLOR
3.851
500
Bruker
DRX
GLU
1
n
1
GLU
1
A
VAL
2
n
2
VAL
2
A
THR
3
n
3
THR
3
A
CYS
4
n
4
CYS
4
A
GLU
5
n
5
GLU
5
A
PRO
6
n
6
PRO
6
A
GLY
7
n
7
GLY
7
A
THR
8
n
8
THR
8
A
THR
9
n
9
THR
9
A
PHE
10
n
10
PHE
10
A
LYS
11
n
11
LYS
11
A
ASP
12
n
12
ASP
12
A
LYS
13
n
13
LYS
13
A
CYS
14
n
14
CYS
14
A
ASN
15
n
15
ASN
15
A
THR
16
n
16
THR
16
A
CYS
17
n
17
CYS
17
A
ARG
18
n
18
ARG
18
A
CYS
19
n
19
CYS
19
A
GLY
20
n
20
GLY
20
A
SER
21
n
21
SER
21
A
ASP
22
n
22
ASP
22
A
GLY
23
n
23
GLY
23
A
LYS
24
n
24
LYS
24
A
SER
25
n
25
SER
25
A
ALA
26
n
26
ALA
26
A
ALA
27
n
27
ALA
27
A
CYS
28
n
28
CYS
28
A
THR
29
n
29
THR
29
A
LEU
30
n
30
LEU
30
A
LYS
31
n
31
LYS
31
A
ALA
32
n
32
ALA
32
A
CYS
33
n
33
CYS
33
A
PRO
34
n
34
PRO
34
A
GLN
35
n
35
GLN
35
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
A
N
PHE
10
A
N
PHE
10
A
O
CYS
17
A
O
CYS
17
A
N
ARG
18
A
N
ARG
18
A
O
ALA
27
A
O
ALA
27
1
A
A
H
O
GLY
SER
20
25
1.44
2
A
A
H
O
GLY
SER
20
25
1.47
5
A
A
H
O
GLY
SER
20
25
1.57
7
A
A
H
O
GLY
SER
20
25
1.56
9
A
A
H
O
GLY
SER
20
25
1.55
10
A
A
H
O
GLY
SER
20
25
1.53
1
A
ARG
18
0.226
SIDE CHAIN
2
A
ARG
18
0.200
SIDE CHAIN
3
A
ARG
18
0.289
SIDE CHAIN
4
A
ARG
18
0.248
SIDE CHAIN
5
A
ARG
18
0.248
SIDE CHAIN
6
A
ARG
18
0.318
SIDE CHAIN
7
A
ARG
18
0.144
SIDE CHAIN
8
A
ARG
18
0.138
SIDE CHAIN
9
A
ARG
18
0.123
SIDE CHAIN
10
A
ARG
18
0.243
SIDE CHAIN
1
A
THR
8
-154.14
-33.31
1
A
THR
9
42.65
-172.62
1
A
PHE
10
176.52
-173.30
1
A
LYS
13
26.66
-105.31
1
A
LYS
24
-145.14
11.92
1
A
CYS
28
61.87
107.02
1
A
LEU
30
57.95
90.25
1
A
ALA
32
174.00
150.51
1
A
CYS
33
-178.60
97.12
2
A
THR
8
-162.51
-34.49
2
A
THR
9
41.01
-169.29
2
A
PHE
10
176.45
-169.67
2
A
LYS
13
34.59
-120.05
2
A
ASN
15
-170.81
-92.74
2
A
CYS
28
64.66
104.04
2
A
THR
29
-75.22
-76.01
2
A
LEU
30
22.89
108.25
2
A
ALA
32
80.88
145.79
3
A
THR
3
-116.83
79.70
3
A
THR
8
-154.70
-32.56
3
A
THR
9
40.49
-166.10
3
A
PHE
10
178.27
-173.51
3
A
LYS
13
45.50
-144.20
3
A
ASN
15
-149.01
-89.44
3
A
LYS
24
-79.16
49.66
3
A
SER
25
-168.56
100.30
3
A
CYS
28
66.68
140.51
3
A
ALA
32
-106.83
-80.20
3
A
CYS
33
58.25
165.16
4
A
THR
3
-169.09
73.05
4
A
THR
8
-147.25
-34.31
4
A
THR
9
42.24
-172.28
4
A
PHE
10
174.08
-169.38
4
A
LYS
13
37.73
-148.02
4
A
CYS
14
-81.42
40.12
4
A
ASN
15
-172.96
-164.24
4
A
LYS
24
-108.00
-93.76
4
A
SER
25
-32.25
115.85
4
A
LYS
31
-136.81
-46.09
4
A
ALA
32
174.97
151.89
4
A
PRO
34
-72.10
-89.09
5
A
THR
8
-151.95
-24.92
5
A
THR
9
45.85
179.45
5
A
PHE
10
177.46
-165.75
5
A
ASP
12
-150.89
-44.37
5
A
LYS
13
-141.61
-138.19
5
A
ASN
15
-125.92
-167.60
5
A
LEU
30
46.72
73.12
5
A
ALA
32
-179.36
-70.63
5
A
CYS
33
58.15
150.52
6
A
THR
3
-49.38
89.98
6
A
THR
8
-149.79
-4.88
6
A
THR
9
40.53
-171.88
6
A
PHE
10
172.21
178.53
6
A
ASP
12
-140.50
-50.15
6
A
LYS
13
-135.95
-142.84
6
A
ASN
15
-128.21
-89.75
6
A
CYS
28
63.05
112.85
6
A
LEU
30
44.55
73.06
6
A
LYS
31
-112.72
51.64
6
A
ALA
32
65.50
152.03
6
A
PRO
34
-72.06
-91.35
7
A
THR
3
-151.64
44.00
7
A
THR
8
-134.43
-32.95
7
A
THR
9
45.23
178.25
7
A
PHE
10
173.31
-162.58
7
A
LYS
13
66.52
-142.55
7
A
LYS
24
51.97
19.96
7
A
LEU
30
-43.58
93.39
7
A
ALA
32
65.13
153.62
7
A
CYS
33
-162.79
97.77
8
A
THR
3
41.37
72.86
8
A
THR
8
-164.90
-31.94
8
A
THR
9
46.85
177.24
8
A
PHE
10
175.33
-169.73
8
A
ASP
12
-142.32
-57.44
8
A
LYS
13
-117.65
-133.79
8
A
LYS
24
43.64
27.36
8
A
CYS
28
59.79
94.84
8
A
THR
29
-83.37
44.07
8
A
ALA
32
69.80
151.57
9
A
VAL
2
58.64
-78.65
9
A
THR
3
49.73
90.04
9
A
THR
8
-134.25
-30.06
9
A
THR
9
42.69
-173.40
9
A
PHE
10
173.97
-165.12
9
A
LYS
13
-137.18
-127.20
9
A
CYS
28
65.35
122.35
9
A
LEU
30
59.33
-141.49
9
A
LYS
31
57.59
14.36
9
A
CYS
33
62.76
131.03
10
A
VAL
2
-90.43
-82.65
10
A
THR
3
38.07
40.38
10
A
THR
8
-162.10
-32.89
10
A
THR
9
43.43
-173.59
10
A
PHE
10
172.64
178.89
10
A
ASP
12
-134.30
-48.19
10
A
LYS
13
-126.22
-111.68
10
A
ASN
15
-169.22
-88.10
10
A
THR
16
175.27
173.41
10
A
SER
25
-165.09
102.18
10
A
CYS
28
61.24
105.04
10
A
LYS
31
-145.52
-41.78
10
A
ALA
32
-143.49
-57.68
10
A
CYS
33
49.62
98.61
SOLUTION STRUCTURE OF THE SMALL SERINE PROTEASE INHIBITOR SGCI
1
N
N
disulf
2.022
A
CYS
4
A
SG
CYS
4
1_555
A
CYS
19
A
SG
CYS
19
1_555
disulf
2.022
A
CYS
14
A
SG
CYS
14
1_555
A
CYS
33
A
SG
CYS
33
1_555
disulf
2.020
A
CYS
17
A
SG
CYS
17
1_555
A
CYS
28
A
SG
CYS
28
1_555
HYDROLASE
Proteinase inhibitor, SGCI, HYDROLASE
SGP1_SCHGR
UNP
1
1
O46162
MKLALALCAAFLLVVLVQAEQECTPGQTKKQDCNTCNCTPTGVWACTRKGCPPHKREVTCEPGTTFKDKCNTCRCGSDGK
SAACTLKACPQK
57
91
1KGM
1
35
O46162
A
1
1
35
3
anti-parallel
anti-parallel
A
PHE
10
A
PHE
10
A
LYS
11
A
LYS
11
A
THR
16
A
THR
16
A
CYS
19
A
CYS
19
A
ALA
26
A
ALA
26
A
CYS
28
A
CYS
28